Introduction The emergence of nitrosamines as genotoxic impurities has triggered global regulatory scrutiny, necessitating a proactive approach to nitrosamine risk […]
Nitrosamine Risk Assessment for NDAs: Regulatory Requirements and Testing Solutions Read More »
Introduction As Health Canada tightens its regulatory oversight on pharmaceutical impurities, nitrosamine impurity testing for Health Canada has become a
Introduction When pharmaceutical and biotechnology companies seek Extractables and Leachables (E&L) testing services , one aspect is to have idea
Cost of Extractables and Leachables Testing: What Influences the Price? Read More »
Introduction: Extractables and Leachables (E&L) Testing for Inhalation and Nasal Drug Products has become a regulatory imperative in 2025. Given
Introduction E&L studies for pharmaceutical packaging are essential for ensuring the safety, quality, and regulatory compliance of drug products. These
E&L Studies for Pharmaceutical Packaging: A Step-by-Step Guide Read More »
In pharmaceutical and biopharmaceutical development, regulatory expectations for safety have become more stringent. One area where this is especially evident
USP and : What They Mean for Your Extractables and Leachables Strategy Read More »
In pharmaceutical and medical device development, Extractables and Leachables Analysis plays a critical role in ensuring patient safety and regulatory
Peptide sequencing of GLP1 receptor agonists is a crucial analytical requirement in the development and validation of GLP1-based therapeutics. At
Case Study: Successful Peptide Sequencing of GLP1 Receptor Agonists Read More »
Introduction Peptide sequencing of Semaglutide is a critical analytical process in the development and regulatory submission of GLP-1 receptor agonist-based
In 2025, Custom Nitrosamine Confirmatory Testing has become an essential component of regulatory compliance for pharmaceutical manufacturers. The industry has
Top 5 APIs That Require Custom Nitrosamine Confirmatory Testing in 2025 Read More »
